查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1701961

2025 年至 2033 年血浆分馏市场报告（按产品、产业、应用、最终用户和地区）

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024年全球血浆分离市场规模达264亿美元。展望未来，预计2033年市场规模将达到414亿美元，2025-2033年期间的成长率（CAGR）为4.86%。慢性病盛行率的上升、技术进步以及医疗保健投资的增加是推动市场成长的一些主要因素。

血浆分馏是指将捐赠血浆进行下游加工，製成救命的疗法和药品。它使用机械分离方法（例如离心、深层过滤、沉淀和色谱法）将血浆分解成单一蛋白质或血浆级分。如今，几种现代分馏过程利用酒精浓度、时间、温度和 pH 值来提取特定的治疗性蛋白质。此外，多年来技术复杂性的不断增加以及过程中病毒减少治疗的引入促进了新蛋白质疗法的开发以及产品纯度和品质的提高。

血浆分馏市场趋势：

从人类血浆中分离出的蛋白质产品是一类重要的治疗药物，广泛用于预防、控制和治疗危及生命的疾病，例如感染、先天性缺陷、罕见血液疾病、免疫疾病和自体免疫疾病。全球相当一部分人口中这些疾病的盛行率显着上升是推动市场成长的关键因素之一。此外，由于许多国家的管理机构对生物製品的品质保证实施了严格的规定和标准控制和设置，製造商正在开发具有额外安全功能的血浆分馏。除此之外，市场参与者正在资助研发（R&D）活动，以推动血浆生产技术的进步，提高产品功效并增强免疫球蛋白G（IgG）的回收率，从而分离新的血浆蛋白。此外，他们也致力于开发价格合理的病毒灭活和处理技术，以便安全利用当地的血浆资源。这与不断增长的提高产量、保持製程经济性以及管理日益增加的监管要求的需求相结合，预计将在未来几年提供良好的市场前景。

本报告回答的关键问题

  • 2024 年全球血浆分馏市场规模为何？ 2025 年至 2033 年期间全球血浆分馏市场的预期成长率为何？
  • COVID-19 对全球血浆分馏市场有何影响？
  • 推动全球血浆分馏市场发展的关键因素有哪些？
  • 根据产品，全球血浆分馏市场是如何分布的？
  • 全球血浆分离市场按产业分類的分布如何？
  • 根据应用，全球血浆分馏市场是如何分布的？
  • 根据最终用户，全球血浆分馏市场是如何分布的？
  • 全球血浆分馏市场的主要区域有哪些？
  • 全球血浆分馏市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球血浆分馏市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 免疫球蛋白
  • 白蛋白
  • 凝血因子Ⅷ
  • 凝血因子 IX

第七章：市场区隔：依行业

  • 私部门
  • 公部门

第 8 章：市场区隔：按应用

  • 神经病学
  • 免疫学
  • 血液学
  • 其他应用

第九章：市场区隔：依最终用户

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ADMA Biologics
    • Bio Products Laboratory Ltd.
    • Boccard
    • Grifols, SA
    • Hemarus Therapeutics Limited
    • Intas Pharmaceuticals Limited
    • LFB SA
    • Merck Group
    • Octapharma AG
    • PlasmaGen BioSciences Pvt. Ltd.
    • SK Plasma Co. Ltd.
    • Virchow Biotech Private Limited
Product Code: SR112025A5973

The global plasma fractionation market size reached USD 26.4 Billion in 2024. Looking forward, the market is expected to reach USD 41.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.86% during 2025-2033. The rising prevalence of chronic diseases, technological advancements, and the increasing investment in healthcare are some of the major factors driving the market growth.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX

Breakup by Sector:

  • Private Sector
  • Public Sector

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global plasma fractionation market in 2024?
  • 2.What is the expected growth rate of the global plasma fractionation market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global plasma fractionation market?
  • 4.What are the key factors driving the global plasma fractionation market?
  • 5.What is the breakup of the global plasma fractionation market based on the product?
  • 6.What is the breakup of the global plasma fractionation market based on the sector?
  • 7.What is the breakup of the global plasma fractionation market based on the application?
  • 8.What is the breakup of the global plasma fractionation market based on the end user?
  • 9.What are the key regions in the global plasma fractionation market?
  • 10.Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coagulation factor VIII
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Coagulation factor IX
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Public Sector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Other Applications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ADMA Biologics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bio Products Laboratory Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boccard
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Grifols, S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hemarus Therapeutics Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Intas Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 LFB S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck Group
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Octapharma AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 SK Plasma Co. Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Virchow Biotech Private Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
  • Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2024
  • Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
  • Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
  • Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million USD), 2025-2033
  • Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Plasma Fractionation Market: Competitive Structure
  • Table 8: Global: Plasma Fractionation Market: Key Players